HYACORP MLF2® BODY CONTOURING

HYAcorp MLF2 is intended to be used as a means of restoring lost volume and contouring body surfaces. The depth of the injection can vary depending on the treatment site, the subcutaneous application, and the supraperiostal application.

• Buttocks
• Calves
• Correction of concave deformities

Contouring the body with HYAcorp MLF2 ensures that the volume of the buttocks and other parts of the body is increased in a natural way.

HYAcorp MLF2 is a Hyaluronic Acid body filler with a bigger particle size, ideal for giving volume to larger areas of the body. It can help:

• Enhance the Buttocks
• Reshape the Calves
• Improve Body Contours
• Correct concave deformities
• Stimulate Collagen and Elastin Production
• Reduce the Appearance of Cellulite
• Alleviate/Rectify Hip dips

• HYAcorp MLF2 is an absorbable skin implant with a high level of purity.
• It is a medical device intended for single use only and is produced from hyaluronic acid of non-animal origin.
• HYAcorp MLF2 is a sterile, apyrogenic, viscoelastic, biologically compatible (nonimmunising, non-inflammatory, non-toxic) gel implant that is insoluble in water and produced from hyaluronic acid obtained by fermentation.

1. Patient Consultation: Begin with a comprehensive consultation to understand the patient's aesthetic objectives and discuss realistic expectations. Evaluate the patient's medical history as certain conditions may prevent the use of Hyacorp MLF2.
2. Treatment Planning: Identify the areas of the body that require volume enhancement. Hyacorp MLF2 is particularly effective for contouring and volumizing areas like the buttocks and calves.
3. Preparation: Cleanse the treatment area thoroughly and consider applying a topical anesthetic to minimize discomfort during the procedure.
4. Injection Technique: Inject Hyacorp MLF2 using a 27 to 29 G needle that is 12 to 13 mm long. The product should be implanted at a 30° to 45° angle into the mid to deep dermis using a linear-retrograde technique.
5. Dosage and Spacing: Each injection point should receive 0.1 to 0.2 ml of the product, with individual injection points spaced approximately 1.5 cm apart. After injection, massage the treated areas to distribute the product evenly.
6. Dosage Adjustments: The amount of product used may vary based on the patient's BMI and degree of skin laxity.
7. Follow-Up Sessions: Schedule a follow-up appointment to assess the results and plan any further treatments if necessary.

Contraindications

• HYAcorp MLF2 must not be used on patients who:
• have a tendency to hypertrophic and keloid scarring
• have an intolerance to gram-positive bacteria
• are prone to active inflammatory or infectious processes
• are suffering from acute or chronic skin diseases
• are undergoing anti-coagulant therapy
• have a known allergy to hyaluronic acid
• are suffering from autoimmune diseases
• No clinical data is available on the administration of the product during pregnancy or lactation or on its administration to adolescents under 18 years of age.
• Patients with multiple allergies should be excluded from treatment. The use of HYAcorp MLF2 in the facial area is contraindicated.
• HYAcorp MLF2 is intended for subcutaneous and/or supraperiostal application only. The use of HYAcorp MLF2 for breast and genital augmentation is contraindicated.

After-care

The area treated must not be exposed to excessive heat (sun, solarium, laser, and IPL) or cold. Patients should refrain from sporting activities for a few days. The injection area should not be massaged in the days following the injection and not exposed to excessive pressure.